In breast carcinoma, NUCKS1 exhibited higher expression than other investigated markers (including Ki67, estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, and cytokeratin 5/6) [33]. This evidence concerns the gene ERBB2 and breast carcinoma.